CASEY ERELLI: Open Payments
NPI 1700409893 · AMHERST, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,634 in 75 payments from 15 companies in 2025. Trend: 2023 $2,212 · 2024 $2,060 · 2025 $1,634
Food & beverage: $1,634
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $357 |
| GlaxoSmithKline, LLC. | 12 | $202 |
| Amgen Inc. | 10 | $161 |
| Regeneron Healthcare Solutions, Inc. | 7 | $156 |
| CSL Behring | 4 | $108 |
| Novartis Pharmaceuticals Corporation | 5 | $106 |
| PFIZER INC. | 4 | $92 |
| Grifols USA, LLC | 3 | $87 |
| Lilly USA, LLC | 3 | $84 |
| GENZYME CORPORATION | 4 | $78 |
Products named: TEZSPIRE, FASENRA, DUPIXENT, TRELEGY ELLIPTA, AIRSUPRA, EBGLYSS, CIBINQO, Xembify.
Industry payments across MA — which companies pay providers there.
